AspyreRx is the only FDA-authorized, fully digital, and therefore easily accessible and scalable, lifestyle intervention designed to improve type 2 diabetes (T2D) outcomes. It is backed by robust data from a randomized controlled trial (RCT) demonstrating clinically meaningful and sustained reduction in A1c as well as improvements in other markers of cardiometabolic health when used up to 180 days.